(Q85013806)
Statements
A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin (English)
Mark Kowalski
Jacinthe Guindon
Louise Brazas
Celine Moore
Joycelyn Entwistle
Jeannick Cizeau
Michael A S Jewett
Glen C MacDonald
19 September 2012